Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

Multiple Sclerosis Therapeutics Marketis is growing with a CAGR of 6.10% during the forecast period 2026-2035. The Multiple Sclerosis Therapeutics Market emerges as a key focus in DataM Intelligence l...

The Global market for dementia and Alzheimer's disease treatments is anticipated to expand from USD 12.18 billion in 2025 to USD 17.91 billion by 2031, reflecting a compound annual growth rate of 6.64...

Psychotherapeutic Drugs Marketis is growing with a CAGR of 5.90% during the forecast period 2026-2035. The Psychotherapeutic Drugs Market emerges as a key focus in DataM Intelligence latest in-depth a...

Alzheimer’s Disease Therapeutics Market reached US$ 5.38 billion in 2025 and is expected to reach US$ 17.98 billion by 2033, growing with a CAGR of 14.32% during the forecast period 2026-2033. The Alz...

Idiopathic Hypersomnia Treatment Market reached US$ 1.48 billion in 2025 and is expected to reach US$ 3.1 billion by 2033, growing with a CAGR of 8.90% during the forecast period 2026-2033. The Idiopa...

Major Depressive Disorder Market reached US$ 7.44 billion in 2025 and is expected to reach US$ 14.57 billion by 2033, growing with a CAGR of 8.80% during the forecast period 2026-2033. The Major Depre...

According to Stratistics MRC, the Global Antiepileptic Drugs Market is accounted for $22.3 billion in 2026 and is expected to reach $36.9 billion by 2034 growing at a CAGR of 6.5% during the forecast...

According to Stratistics MRC, the Global Tardive Dyskinesia Therapeutics Market is accounted for $3.4 billion in 2026 and is expected to reach $8.0billion by 2034 growing at a CAGR of 11.1% during the...

Frontotemporal Disorders Treatment Marketis is growing with a CAGR of 8.60% during the forecast period 2026-2035. The Frontotemporal Disorders Treatment Market emerges as a key focus in DataM Intellig...

Acute Agitation and Aggression Treatment Marketis is growing with a CAGR of 8.80% during the forecast period 2026-2035. The Acute Agitation and Aggression Treatment Market emerges as a key focus in Da...

Postpartum Depression Market reached USD 15.5 billion in 2025 and is expected to reach USD 93.6 billion by 2033, growing with a CAGR of 30.50% during the forecast period 2026-2033. The Postpartum Depr...

Disease-Modifying Therapies (DMT) Market reached US$ 165.88 Billion in 2025 and is expected to reach US$ 281.88 Billion by 2033, growing with a CAGR of 6.43% during the forecast period 2026-2033. The...

Acute Migraine Drugs Market reached US$ 12.8 billion in 2025 and is expected to reach US$ 23.5 billion by 2033, growing with a CAGR of 8.10% during the forecast period 2026-2033. The Acute Migraine Dr...

The global selective serotonin reuptake inhibitors market size was valued at USD 19.51 billion in 2025 and is projected to reach USD 30.25 billion by 2033, growing at a CAGR of 5.70% from 2026 to 2033...

The Neurofibromatosis Type 2 Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...

Charcot-Marie-Tooth (CMT) Disease Market reached US$ 746.99 Million in 2025 and is expected to reach US$ 1,166.98 Million by 2033, growing with a CAGR of 5.80% during the forecast period 2026-2033. Th...

According to our (Global Info Research) latest study, the global 5-HT1B/1D Receptor Agonists market size was valued at US$ 1292 million in 2025 and is forecast to a readjusted size of US$ 1663 million...

According to our (Global Info Research) latest study, the global Eletriptan Tablets market size was valued at US$ 151 million in 2025 and is forecast to a readjusted size of US$ 187 million by 2032 wi...

According to our (Global Info Research) latest study, the global Fast-Acting Migraine Medications market size was valued at US$ 3177 million in 2025 and is forecast to a readjusted size of US$ 3862 mi...

According to our (Global Info Research) latest study, the global Migraine-Specific Analgesics market size was valued at US$ 2045 million in 2025 and is forecast to a readjusted size of US$ 2556 millio...

According to our (Global Info Research) latest study, the global Prescription Drugs for Acute Migraine market size was valued at US$ 2045 million in 2025 and is forecast to a readjusted size of US$ 25...

According to our (Global Info Research) latest study, the global Sumatriptan Subcutaneous Injection market size was valued at US$ 181 million in 2025 and is forecast to a readjusted size of US$ 247 mi...

According to our (Global Info Research) latest study, the global Triptan-Class Antimigraine Agents market size was valued at US$ 1292 million in 2025 and is forecast to a readjusted size of US$ 1663 m...

According to our (Global Info Research) latest study, the global Zolmitriptan Preparations market size was valued at US$ 264 million in 2025 and is forecast to a readjusted size of US$ 361 million by...

The global 5-HT1B/1D Receptor Agonists market size is expected to reach $ 1663 million by 2032, rising at a market growth of 3.8% CAGR during the forecast period (2026-2032). 5-HT1B/1D Receptor Agonis...

The global Eletriptan Tablets market size is expected to reach $ 187 million by 2032, rising at a market growth of 3.2% CAGR during the forecast period (2026-2032). Eletriptan Tablets are oral solid d...

The global Fast-Acting Migraine Medications market size is expected to reach $ 3862 million by 2032, rising at a market growth of 2.8% CAGR during the forecast period (2026-2032). Fast-acting migraine...

The global Migraine-Specific Analgesics market size is expected to reach $ 2556 million by 2032, rising at a market growth of 3.2% CAGR during the forecast period (2026-2032). Migraine-Specific Analge...

The global Prescription Drugs for Acute Migraine market size is expected to reach $ 2556 million by 2032, rising at a market growth of 3.2% CAGR during the forecast period (2026-2032). Prescription Dr...

The global Sumatriptan Subcutaneous Injection market size is expected to reach $ 247 million by 2032, rising at a market growth of 4.5% CAGR during the forecast period (2026-2032). Sumatriptan Subcuta...

The global Triptan-Class Antimigraine Agents market size is expected to reach $ 1663 million by 2032, rising at a market growth of 3.8% CAGR during the forecast period (2026-2032). Triptan-Class Antim...

The global Zolmitriptan Preparations market size is expected to reach $ 361 million by 2032, rising at a market growth of 4.7% CAGR during the forecast period (2026-2032). Zolmitriptan preparations re...

... the severity of the attacks. SCOPE OF THE REPORT: The global Acute Migraine Treatments market is valued at xx million USD in 2018 and is expected to ... top players in global market, and splits the Acute Migraine Treatments market by product type and applications/end industries. Market Segment by Companies, ...

According to our (Global Info Research) latest study, the global Migraine Headache Drugs market size was valued at US$ 3599 million in 2025 and is forecast to a readjusted size of US$ 4348 million by...

According to our (Global Info Research) latest study, the global Anti-Migraine Drugs market size was valued at US$ 3599 million in 2025 and is forecast to a readjusted size of US$ 4348 million by 2032...

According to our (Global Info Research) latest study, the global Migraine Therapeutics market size was valued at US$ 3599 million in 2025 and is forecast to a readjusted size of US$ 4348 million by 20...

According to our (Global Info Research) latest study, the global Migraine Treatment Medication market size was valued at US$ 3599 million in 2025 and is forecast to a readjusted size of US$ 4348 milli...

The global migraine drugs market size was valued at USD 4.60 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.50 Billion by 2034, exhibiting a CAGR of 3.90% from 2026-...

The global Alzheimer’s drugs market size reached USD 8.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.67% du...

The global amyotrophic lateral sclerosis treatment market size was valued at USD 819.7 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 1,177.7 Million by 2034, exhibiti...

The global central nervous system (CNS) therapeutics market size reached USD 157.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 261.0 Billion by 2034, exhibiting a gro...

The global Huntington’s disease treatment market size was valued at USD 679.3 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 2,829.2 Million by 2034, exhibiting a CAGR...

The 7 major epilepsy markets reached a value of USD 2.05 Billion in 2025. Looking forward, IMARC Group expects the 7MM to reach USD 2.71 Billion by 2036, exhibiting a growth rate (CAGR) of 2.58% durin...

The global narcolepsy drugs market size reached USD 3.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.38% duri...

The Gabapentin Market is projected to grow from USD 2.4 billion in 2026 to USD 3.0 billion in 2031, reflecting a 4.6% CAGR. The global gabapentin market operates in a post-patent, generic-dominant par...

The global Quetiapine Fumarate Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Quetiapine is an antips...

The global Atomoxetine Hydrochloride Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Atomoxetine hydr...

The global Huntington Disease Medications market size is predicted to grow from US$ 3988 million in 2025 to US$ 11190 million in 2032; it is expected to grow at a CAGR of 16.2% from 2026 to 2032. Hunt...

The global Norepinephrine Reuptake Inhibitors market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Norepinephrine r...

The global amitriptyline hydrochloride market size was estimated at USD 381.17 million in 2025 and is projected to reach USD 510.20 million by 2033, growing at a CAGR of 3.78% from 2026 to 2033. The g...